Desvenlafaxine Succinate Hydrate [386750-22-7]
D1874
Estimated Purity≥99%
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameDesvenlafaxine Succinate Hydrate [386750-22-7]
- Delivery Days Customer7
- CertificationResearch Use Only
- Estimated Purity≥99%
- FormatSoluble in water (50 mM), and DMSO (100 mM)
- Scientific DescriptionVenlafaxine metabolite; SERT and NET inhibitor.; Pristiq
- Storage InstructionAmbient
- UNSPSC12352200
References
- Song J, Yin J, Chen JD. Acute and chronic effects of desvenlafaxine on gastrointestinal transit and motility in dogs. Neurogastroenterol Motil. 2013 Jul 19. [Epub ahead of print]. PMID: 23865827. Sun Z, Hao Y, Zhang M. Efficacy and safety of desvenlafaxine treatment for hot flashes associated with menopause: a meta-analysis of randomized controlled trials. Gynecol Obstet Invest. 2013;75(4):255-62. PMID: 23548358. DeMartinis NA, Yeung PP, Entsuah R, et al. A double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine succinate in the treatment of major depressive disorder. J Clin Psychiatry. 2007 May;68(5):677-88. PMID: 17503976. Deecher DC, Beyer CE, Johnston G, et al. Desvenlafaxine succinate: A new serotonin and norepinephrine reuptake inhibitor. J Pharmacol Exp Ther. 2006 Aug;318(2):657-65. PMID: 16675639.